Alterome Therapeutics is a startup based in Israel, 1 tracked investor.
Based in Israel, Alterome Therapeutics is a startup founded in 2022. Brouky records 1 investor associated with the company.
Alterome Therapeutics is a clinical-stage biotechnology company developing alteration-specific small-molecule targeted therapies for cancer. It is advancing a pipeline that includes ALTA3263, a Phase 1 candidate enrolling patients with advanced solid tumors bearing KRAS mutations.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.